Department of Pharmaceutics, College of Pharmacy, Xinjiang Medical University, Urumqi, China.
Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, China.
Colloids Surf B Biointerfaces. 2017 Nov 1;159:580-585. doi: 10.1016/j.colsurfb.2017.08.028. Epub 2017 Aug 24.
Based on the structurally similar properties of progesterone and cholesterol, chitosan-coated cholesterol-free liposomes (CS-Lipo/Prog) were formulated. CS-Lipo/Prog are spherical and uniform in size (662.1±19.3nm) with positive potential (28.19±1.97mV). The average drug entrapment efficiency (EE) is approximately 80%. The in vitro release profile of CS-Lipo/Prog shows sustained release. The in vitro stability evaluation demonstrated that CS-Lipo/Prog can efficiently shield Prog from degradation in the gastrointestinal tract. CS-Lipo/Prog showed a longer MRT and higher AUC after oral administration to mice than in the control group (progesterone-free). The relative bioavailability of CS-Lipo/Prog was higher than that of progesterone soft capsules (QINING) and Lipo/Prog. Collectively, these findings suggest that cholesterol-free chitosan-coated liposomes are a promising alternative for improving the oral bioavailability of progesterone.
基于孕酮和胆固醇结构相似的性质,制备了壳聚糖包覆无胆固醇脂质体(CS-Lipo/Prog)。CS-Lipo/Prog 呈球形且粒径均一(662.1±19.3nm),带正电(28.19±1.97mV)。平均药物包封效率(EE)约为 80%。CS-Lipo/Prog 的体外释放曲线呈缓释特征。体外稳定性评价表明 CS-Lipo/Prog 可以有效防止 Prog 在胃肠道中降解。CS-Lipo/Prog 经小鼠口服后 MRT 延长,AUC 高于对照组(无孕酮)。CS-Lipo/Prog 的相对生物利用度高于 QINING 黄体酮软胶囊和 Lipo/Prog。综上所述,这些结果表明无胆固醇壳聚糖包覆脂质体是提高孕酮口服生物利用度的一种有前途的方法。